TrialHepatology international2016

A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus.

Young-Suk Lim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.